BioCentury
ARTICLE | Clinical News

Cotinine: Completed a Phase II trial, with a significant number of users of the agent abstaining from smoking during the study, compared to placebo-treated smok

April 24, 1995 7:00 AM UTC

LecTec Corp. (LECT), Minnetonka, Minn. Product: Cotinine, a metabolite of nicotine, in pill form Use: Smoking cessation Status: Completed a Phase II trial, with a significant number of users of the ag...